Highlights Absci Corporation

Equities

ABSI

US00091E1091

Real-time Estimate Cboe BZX Other stock markets 01:49:36 2024-04-30 pm EDT			5-day change	1st Jan Change
4.765 ^USD	-0.31%		+1.91%	+14.29%

Mar. 21	Earnings Flash (ABSI) ABSCI CORPORATION Reports Q4 Revenue $338,000	MT
Mar. 21	Absci Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (ABSI) ABSCI CORPORATION Reports Q4 Revenue $338,000	Mar. 21	MT
Absci Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Absci Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
Absci Initiates IND-Enabling Studies for Abs-101, A Potential Best-In-Class Anti-Tl1a Antibody De Novo Designed and Optimized Using Generative Ai	Feb. 21	CI
Absci Corporation to Present Preclinical Data for ABS-101, A Potential Best-In-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 08	CI
Absci Corporation and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline	Dec. 20	CI
Absci Working With AstraZeneca to Use AI Platform to Discover Oncology Candidate	Dec. 04	MT
Absci Corporation Announces Collaboration with Astrazeneca to Advance Ai-Driven Oncology Candidate	Dec. 04	CI
UK Stocks-Factors to watch on Dec 4	Dec. 04	RE
AstraZeneca, Absci Enter $247 Million Partnership to Develop New Cancer Treatment	Dec. 03	MT
Absci's Q3 Net Loss Narrows, Revenue Falls	Nov. 14	MT
Earnings Flash (ABSI) ABSCI CORPORATION Reports Q3 Revenue $744,000	Nov. 14	MT
Absci Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Almirall Teams Up with Absci on AI-designed Dermatological Disease Treatments	Nov. 14	MT
Absci Enters AI Drug Discovery Pact With Almirall to Develop New Therapies for Dermatological Diseases; Shares Surge Premarket	Nov. 14	MT
Absci Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Earnings Flash (ABSI) ABSCI CORPORATION Posts Q2 Revenue $3.4M	23-08-14	MT
Absci Corporation and California Institute of Technology Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development	23-08-10	CI
Absci Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Earnings Flash (ABSI) ABSCI CORPORATION Posts Q1 Revenue $1.3M	23-05-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Absci Corporation

Equities

ABSI

US00091E1091

Highlights

Filters